49 h. ago Dr Oz says drug exec who fainted in Oval Office is recovering: ‘He’s doing much better’

Dr Oz also directly addressed viewers and urged them to follow his advice if they think that someone near them is about to faint

Events

63 h. ago White House guest suddenly collapses in front of Donald Trump live on TV inside the Oval Office

An attendee at President Donald Trump's drug pricing event on Thursday collapsed.

Society

65 h. ago Trump watches in horror as top executive collapses at White House press conference

Novo Nordisk executive Gordon Findlay collapsed during a press conference in the Oval Office at the White House on Thursday as President Trump watched on in horror

Events

65 h. ago Novo Nordisk executive Gordon Findlay COLLAPSES in front of Trump in Oval Office

The pharmaceutical executive was standing behind Donald Trump at a press conference announcement inside the White House for a new deal for weight-loss medications

Politics

65 h. ago Pharma executive passes out in Oval Office while standing behind Trump for drug price announcement

Pharmaceutical representative was part of a ‘major announcement’ to make GLP-1s more affordable

Politics

65 h. ago Official passes out in Oval Office while standing behind Trump for drug price announcement

Pharmaceutical representative was part of a ‘major announcement’ to make GLP-1s more affordable

Politics

2 d. ago ‘Live, laugh, lose’: Trump hammered over golden Oval Office sign tacked to White House wall

Donald Trump has been hammered on social media for taping a golden “Oval Office” sign onto the walls of the White House, while the government shutdown enters its 37th day

Society

3 d. ago Trump adds a new sign labeling ‘The Oval Office’ ... right outside the Oval Office

The gilded letters outside the world’s most famous office resemble the typeface used on the logo for his Mar-a-Lago club

Politics

3 d. ago Ozempic maker struggles as it loses ground to rivals in weight

Novo Nordisk cuts sales and profit forecasts as it continues to lose ground to Mounjaro firm Eli LillyThe maker of Ozempic and Wegovy has cut its sales and profit forecasts as it continues to fall behind in the competitive market for obesity and diabetes treatments.Novo Nordisk’s chief executive, Mike Doustdar, who took the reins in August, said the reduced guidance was because of “the lower growth expectations for our GLP-1 treatments”. Continue reading...

Politics

4 d. ago Ozempic maker Novo Nordisk cuts sales and profit forecasts again

Downgrade comes as Danish company continues to lose ground to Mounjaro firm Eli Lilly in weight-loss drug marketThe maker of Ozempic and Wegovy has cut its sales and profit forecasts as it continues to fall behind in the competitive market for obesity and diabetes treatments.Novo Nordisk’s chief executive, Mike Doustdar, who took the reins in August, said the reduced guidance was because of “the lower growth expectations for our GLP-1 treatments”. Continue reading...

Economics

2 w. ago White House East Wing will be torn down ‘within days’ even as no plans filed for Trump’s new ballroom

Demolition has drawn fierce backlash, with National Trust for Historic Preservation saying plans are ‘legally required’Trump takes a wrecking ball to White House in on-the-nose metaphorTrump administration officials confirmed to various outlets on Wednesday that the White House’s East Wing will be demolished “within days”, a revelation given the administration has not submitted plans for the new ballroom to the federal agency that oversees construction of federal buildings.In discussion with reporters in the Oval Office on Wednesday, Donald Trump was asked by Jeff Mason of Reuters to respond to the widespread surprise that the entire East Wing is being torn down. Trump said that the wing he described as a separate building “was never thought of as being much; it was a very small building”. Continue reading...

Politics

2 w. ago The Guardian view on Ukraine peace talks: Europe must ensure Zelenskyy can resist Trump’s bullying | Editorial

The US president’s attempts to broker a deal fail to distinguish between the aggressor and the victim. No just agreement is possible on that basisIt wasn’t quite the calamity of February, when Volodymyr Zelenskyy was publicly humiliated in the Oval Office by Donald Trump and his vice-president, JD Vance. But the Ukrainian president’s latest visit to the White House on Friday was, by all accounts, a disquieting experience. Mr Trump’s public musings before the meeting suggested that his stance had hardened towards Vladimir Putin, to the strategically significant extent of being willing to sell long-range Tomahawk missiles to Kyiv. But by the time Mr Zelenskyy arrived in Washington, the US president had changed his mind, instead lecturing his guest on the need to make territorial concessions to Russia.So far, so familiar. Since being re-elected, Mr Trump has repeatedly resiled from following up tough talk on Russia with meaningful action. Faux deadlines for Mr Putin to make substa...

Politics

4 w. ago Trump’s latest potential DC makeover raises eyebrows in late

Reporters spotted a 3D model of the proposed arch on Trump’s Oval Office desk earlier this week

Politics